grant

Role of ncRNA Surveillance Complex "RNA Exosome" in Class Switch Recombination and Somatic Hypermutation

Organization COLUMBIA UNIVERSITY HEALTH SCIENCESLocation NEW YORK, UNITED STATESPosted 7 May 2012Deadline 30 Apr 2027
NIHUS FederalResearch GrantFY20263-D3-Dimensional3DAICDAAICDA proteinAID deficiencyAID geneAID proteinAddressAffinityAllelesAllelomorphsAntibodiesAntibody AffinityAntigensArchitectureAssayB blood cellsB cellB cellsB-Cell DeficiencyB-CellsB-LymphocytesB-cellBindingBioassayBiochemicalBiological AssayCDA2 proteinCatalysisCausalityCell IsolationCell LineCell SegregationCell SeparationCell Separation TechnologyCellLineChromatinChromosomal dislocationChromosomal translocationClass SwitchingClass SwitchingsComplexCytidineCytosine RibonucleosideCytosine RibosideDLBCLDNADNA Polymerase IIDNA Polymerase epsilonDNA SequenceDNA StructureDNA mutationDNA-Dependent DNA Polymerase IIDNA-Dependent RNA Polymerase IIDataDeaminationDegenerative Neurologic DisordersDeoxyribonucleic AcidDevelopmentDiffuse Large B-Cell LymphomaDiseaseDisorderDouble-Stranded RNAElementsEngineering / ArchitectureEnhancersEtiologyExonsExonucleaseFamilyFunctional RNAGene TranscriptionGenerationsGenesGeneticGenetic ChangeGenetic TranscriptionGenetic TranslocationGenetic defectGenetic mutationGenetics-MutagenesisGenomeGenome InstabilityGenomic InstabilityGenomicsGerm LinesGerminal CenterGrantHIGM2Heavy-Chain ImmunoglobulinsHybridsHyper IgM syndrome type 2IGHIGH@ gene clusterIg GenesIg Somatic HypermutationIgH locusImmune GlobulinsImmunityImmunodeficiency DisorderImmunodeficiency SyndromeImmunoglobulin Class SwitchingImmunoglobulin Class SwitchingsImmunoglobulin GenesImmunoglobulin Heavy Chain GenesImmunoglobulin Heavy GeneImmunoglobulin Heavy LocusImmunoglobulin Isotype-Switch RecombinationImmunoglobulin Somatic HypermutationImmunoglobulin Switch RecombinationImmunoglobulin V(D)J RearrangementImmunoglobulinsImmunologic Deficiency SyndromesImmunological Deficiency SyndromesIsotype SwitchingIsotype SwitchingsKineticsLaboratoriesLifeLight-Chain ImmunoglobulinsLymphomagenesisMacromolecular ComplexesMaintenanceMediatingMiceMice MammalsMolecularMolecular InteractionMultiple MyelomaMurineMusMutagenesisMutagenesis Molecular BiologyMutateMutationNervous System Degenerative DiseasesNeural Degenerative DiseasesNeural degenerative DisordersNeurodegenerative DiseasesNeurodegenerative DisordersNeurologic Degenerative ConditionsNon-Polyadenylated RNANoncoding RNANontranslated RNAOncogenesisOncogenicOutcomePlasma-Cell MyelomaPlayPol IIPreventionProcessPropertyProteinsRNARNA BindingRNA DegradationRNA ExpressionRNA Gene ProductsRNA HelicaseRNA Polymerase BRNA Polymerase IIRNA ProcessingRNA boundRegulationResearch DesignRibonucleic AcidRoleSingle-Stranded DNASiteStrains Cell LinesStructure of germinal center of lymph nodeStudy TypeSwitch RecombinationTechnologyTranscriptTranscriptionTranscriptional ControlTranscriptional RegulationUntranslated RNAV(D)J RearrangementV(D)J RecombinationVDJ rearrangementVDJ recombinationWorkactivation-induced cytidine deaminaseactivation-induced cytidine deaminase deficiencyactivation-induced deaminaseantigen antibody affinitycausationcell sortingchromatin remodelingchromosome dislocationchromosome translocationcofactorcohesincultured cell linedegenerative diseases of motor and sensory neuronsdegenerative neurological diseasesdevelop therapydevelopmentaldisease causationdsRNAexosomegene locusgenetic locusgenome editinggenome mutationgenomic editinggenomic locationgenomic locusglobal gene expressionglobal transcription profilehumoral immunity deficiencyimmune deficiency disorderimmunogenimmunoglobulin heavy chain locusimmunoglobulin structureinterestintervention developmentlarge cell Diffuse non-Hodgkin's lymphomamouse modelmurine modelmyelomamyelomatosisneurodegenerative illnessnoncodingnovelpreventpreventingpromoterpromotorprotein activationrecruitsocial rolesomatic hypermutationssDNAstudy designtherapy developmentthree dimensionaltranscription terminationtranscriptometranscriptomicstreatment developmenttumorigenesisvariable region gene
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

PROJECT SUMMARY
Background: Class switch recombination (CSR) and somatic hypermutation (SHM) are two B lymphocyte

specific processes that mediate antibody diversification. Activation Induced Cytidine Deaminase (AID) is

essential for initiating both of these processes by deaminating cytidine residues in immunoglobulin (Ig) loci

DNA. Despite its specific and indispensible function in the Ig loci, AID has been demonstrated to also

deaminate non-Ig locus genes, with the concomitant negative outcome of catalyzing various oncogenic

translocations that manifest in tumorigenesis. Recent work has indicated that AID's DNA deamination activity

requires its association with transcriptionally stalled RNA polymerase II and the RNA exosome complex. RNA

exosome is a cellular non-coding RNA (ncRNA) processing and/or degradation macromolecular complex. How

ncRNA and RNA exosome facilitate AID's DNA deamination activity is a question we plan to address.

Objective/Hypothesis: We will determine how RNA exosome activity on ncRNAs support AID activity at the

IgH locus and stabilizes 3-dimensional organization of the B cell genome. Specific aims: AIM 1: To understand

the chromatin associated function of noncoding RNAs and RNA exosome in controlling AID activity. AIM 2: To

understand the role of CTCF binding element (cbe) ncRNAs in TADIgH organization. AIM 3: To understand the

role of novel RNA exosome cofactors in regulating AID activity.

Study Design: Using mouse models that are deficient in RNA exosome-mediated RNA degradation, we have

identified regions in the B cell genome that express exosome sensitive ncRNAs and also are mutated by AID.

We will evaluate the mechanism of formation of single-strand DNA structures following localized chromatin

remodeling at these identified AID target DNA sequences. We have discovered a new family of exosome

sensitive ncRNAs that are associated with CTCF-binding elements (CBE), defined as cbeRNAs. We will

evaluate how cbeRNA processing regulates the 3 dimensional topologically associating domain structure of IgH

and influences SHM and CSR efficiencies. Finally, using B cells from TAP-tagged Exosome expressing mouse

model, we have purified and identified chromatin associated RNA exosome co-factors. We will evaluate the role

of RNA exosome co-factor(s) in stimulating AID/RNA exosome complex function.

Disease Relevance: The proposed studies will lead to a better understanding of the mechanisms initiating

AID dependent oncogenesis in B lymphocytes (particularly in the contexts of DLBCL and multiple myeloma) as

well as have direct implications in understanding B lymphocyte-based immunodeficiency syndromes like

Hyper-IgM syndrome type 2. RNA exosome is implicated in many diseases including numerous

neurodegenerative disorders and multiple myeloma and findings from this grant will lead to a better

understanding of the etiologies of the disorders and development of therapies.

Grant Number: 5R01AI099195-15
NIH Institute/Center: NIH

Principal Investigator: Uttiya Basu

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →